Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-23 4:18 pm Purchase | 2025-05-19 | 13G | Cemtrex, Inc. CETX | Mitchell P. Kopin | 13,204 9.990% | 13,204 (New Position) | Filing History |
| 2025-05-23 4:17 pm Purchase | 2025-05-19 | 13G | Sunshine Biopharma, Inc. SBFM | Mitchell P. Kopin | 505,653 9.990% | 505,653 (New Position) | Filing History |
| 2025-05-21 5:19 pm Purchase | 2025-05-15 | 13G | Silo Pharma, Inc. SILO | Mitchell P. Kopin | 784,630 9.990% | 549,103 (+233.14%) | Filing History |
| 2025-05-12 4:08 pm Purchase | 2025-05-06 | 13G | Pasithea Therapeutics Corp. KTTA | Mitchell P. Kopin | 317,863 4.990% | 317,863 (New Position) | Filing History |
| 2025-05-09 4:04 pm Purchase | 2025-03-31 | 13G | INVO Fertility, Inc. IVF | Mitchell P. Kopin | 1,458 4.990% | 1,458 (New Position) | Filing History |
| 2025-05-09 4:04 pm Sale | 2025-03-31 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 2,334 0.400% | -23,913 (-91.11%) | Filing History |
| 2025-05-09 4:03 pm Purchase | 2025-03-31 | 13G | Mustang Bio, Inc. MBIO | Mitchell P. Kopin | 236,452 8.800% | 49,900 (+26.75%) | Filing History |
| 2025-05-09 4:02 pm Purchase | 2025-03-31 | 13G | Color Star Technology Co., Ltd. ADD | Mitchell P. Kopin | 106,748 9.990% | 86,569 (+428.99%) | Filing History |
| 2025-05-09 4:02 pm Sale | 2025-03-31 | 13G | Microbot Medical Inc. MBOT | Mitchell P. Kopin | 2,349,488 6.300% | -322,596 (-12.07%) | Filing History |
| 2025-04-25 4:07 pm Unchanged | 2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-17 4:04 pm Purchase | 2025-04-11 | 13G | Innovative Eyewear, Inc. LUCY | Mitchell P. Kopin | 333,071 9.990% | 206,998 (+164.19%) | Filing History |
| 2025-04-15 5:08 pm Purchase | 2025-04-09 | 13G | Venus Concept Inc. VERO | Mitchell P. Kopin | 37,776 2.600% | 37,776 (New Position) | Filing History |
| 2025-04-14 5:32 pm Purchase | 2025-04-08 | 13G | American Rebel Holdings, Inc. AREB | Mitchell P. Kopin | 7,017 9.990% | 7,017 (New Position) | Filing History |
| 2025-04-09 5:31 pm Unchanged | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-07 4:17 pm Purchase | 2025-04-01 | 13G | GRI Bio, Inc. GRI | Mitchell P. Kopin | 40,261 4.990% | 40,261 (New Position) | Filing History |
| 2025-02-18 06:19 am Purchase | 2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Mitchell P. Kopin | 138,763 4.990% | 138,763 (New Position) | Filing History |
| 2025-02-11 4:53 pm Purchase | 2025-02-05 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Mitchell P. Kopin | 77,358 4.990% | 20,448 (+35.93%) | Filing History |
| 2025-02-11 4:51 pm Purchase | 2025-02-05 | 13G | Mustang Bio, Inc. MBIO | Mitchell P. Kopin | 186,552 9.990% | 186,552 (New Position) | Filing History |
| 2025-02-05 5:15 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 8,663 4.990% | 8,663 (New Position) | Filing History |
| 2025-02-05 5:13 pm Purchase | 2025-01-30 | 13G | SaverOne 2014 Ltd SVRE | Mitchell P. Kopin | 303,073 4.990% | 303,073 (New Position) | Filing History |